Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.49 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | CUL4A | Q13619 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 1/20 | 0.44 |
| ▸ | FNTB | P49356 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23957267 | 0.93 | PTPN1 (0.48) | PTPN1ADORA1SQORNPSR1KDM4E | |
| SCHEMBL23957342 | 0.93 | PTPN1 (0.50) | PTPN1ADORA1SQORNPSR1KDM4E | |
| SCHEMBL4153688 | 0.82 | CA1 (0.52) | SMN1; SMN2 | |
| SCHEMBL17711173 | 0.77 | KIF11 (0.44) | KDM4EALDH1A1FNTAFNTBGRIA2 | |
| SCHEMBL14334683 | 0.77 | SQOR (0.53) | ADORA1SQORNPSR1KDM4ERXFP1 | |
| SCHEMBL23629582 | 0.76 | CA1 (0.43) | PTPN1KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL23045910 | 0.76 | IDO1 (0.42) | ADORA1NPSR1KDM4EMEN1KMT2A | |
| SCHEMBL23629580 | 0.75 | KDM4E (0.45) | PTPN1NPSR1KDM4ERXFP1MEN1 | |
| SCHEMBL9405472 | 0.75 | SQOR (0.51) | PTPN1ADORA1SQORNPSR1KDM4E | |
| SCHEMBL23629590 | 0.75 | KIF11 (0.52) | NPSR1KDM4EALDH1A1MAPTGRIA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12122768-B2 | Benzonitrile derivative, light-emitting material, and light-emitting element using same | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2024-10-22 | — | — | US | disclosed |
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2021-10-28 | — | — | US | disclosed |
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2021-10-28 | — | — | US | disclosed |
| EP-3848352-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | Kyushu University, National University Corporation (JP) | 2021-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12122768-B2 | Benzonitrile derivative, light-emitting material, and light-emitting element using same | INTS9, GTF2I, BRI3BP | PTPN1 4473/4885ADORA1 4272/4885SQOR 1076/4885 |
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | INTS9, GTF2I, BRI3BP | PTPN1 4473/4885ADORA1 4272/4885SQOR 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.